References
- Andrews G. On the promotion of non-drug treatments. British Medical Journal 1984; 289: 994–995
- Andrews G. Prothiaden: the promotion of a good antidepressant. Recent trends in the treatment of depression. Proceedings of the International Symposia. 1986, G Johnston. The Boots Company (Australia) Pty Ltd, Sydney March, 1986
- Goldberg D. Tales from the Vienna woods. Lancet 1983; ii: 393
- Cole J O. Lithium carbonate: some recommendations. American Journal of Psychiatry 1968; 125: 556–667
- Sartorius N, et al. Psychiatric treatment. American Psychiatric Press, Washington 1993
- White K., Simpson G. Combined MAOI-tricyclics antidepressant treatment: a re-evaluation. Journal of Clinical Psychopharmacology 1981; 1: 264–282
- Schmauss M. H, Kapfhammer P., McYr P, Hoff P. Combined MAO-inhibitor and tri(tetra) cyclic antidepressant treatment in therapy resistant depression. Prog. Neuro-Piychopharmacology and Biological Psychiatry 1988; 12: 523–532
- Schukit M, Robins F., Feighner J. Tricyclic antidepressants and monoamine oxidase inhibitors. Archives of General Psychiatry 1971; 24: 509–514
- Morstyn R. Some fallacies of statistical inferences about psychotherapy. Australian and New Zealand Journal of Psychiatry 1003; 27: 101–107
- Hickie I, Hickie C. Correspondence: Ethical standards and clinical practice. Australian and New Zealand Journal of Psychiatry 1993; 27: 157
- Krupnick J L, Pincus H A. The cost-effectiveness of psychotherapy: a plan for research. American Journal of Psychiatry 1992; 10: 1295–1305